Low-Dose Ketamine Guide
Research dose, route, monitoring, depression evidence, side effects, and provider questions before discussing treatment options.
Track the low-dose basics
Dose and route context
Side effects and safety monitoring
Depression and anxiety evidence
Response tracking and follow-up planning
Find what you came here for
Jump straight into the topics with the most coverage on this site.
Comparisons
Clear side-by-side breakdowns of treatment options, delivery methods, costs, and tradeoffs.
Explore comparisons →News
Current research, regulatory updates, access changes, and market developments worth tracking.
Explore news →Safety
Safety, side effects, contraindications, monitoring, and when to involve a clinician.
Explore safety →Research
Clinical evidence, pharmacology, trial summaries, long-term outcomes, and route comparisons.
Explore research →Conditions
Condition-specific explainers for depression, anxiety, pain, PTSD, and other clinical conversations.
Explore conditions →Dosing
18 articles in dosing.
Explore dosing →Understand Low Dose Before You Compare Care
Learn what dose, route, frequency, monitoring, and follow-up can mean in real treatment conversations.
Define the dose context
Understand how dose, route, frequency, body response, and supervision affect what “low dose” means.
Read the evidence carefully
Review condition, safety, sleep, older-adult, and mechanism guides before comparing treatment models.
Prepare follow-up questions
Bring clearer questions about monitoring, side effects, symptom tracking, cost, and booster planning.
Low-Dose Guides Worth Starting With
Longer guides on dosing, depression evidence, safety, routes, and patient basics.
Planning Tools
Use calculators and checklists to organize cost, candidacy, and provider questions.
Ketamine Cost Estimator
Estimate common ketamine therapy cost ranges by route, region, session count, maintenance care, and insurance assumptions.
Candidate Discussion Screener
Organize clinician-facing questions about possible fit, cautions, contraindications, support needs, and next steps.
Provider Evaluation Checklist
Compare clinics and telehealth programs by credentials, screening, monitoring, emergency planning, transparency, and follow-up.
Session Preparation Checklist
Prepare for a ketamine appointment with timing-based reminders for transportation, medication review, fasting instructions, recovery time, and safety planning.
Explore Low-Dose Topics
Dosing, safety, depression, research, access, and patient decision points.
Comparisons
Clear side-by-side breakdowns of treatment options, delivery methods, costs, and tradeoffs.
News
Current research, regulatory updates, access changes, and market developments worth tracking.
Safety
Safety, side effects, contraindications, monitoring, and when to involve a clinician.
Research
Clinical evidence, pharmacology, trial summaries, long-term outcomes, and route comparisons.
Conditions
Condition-specific explainers for depression, anxiety, pain, PTSD, and other clinical conversations.
Dosing
18 articles in dosing.
Protocols
12 articles in protocols.
At Home Monitoring
9 articles in at home monitoring.
Clinical
6 articles in clinical.
Pharmacokinetics
6 articles in pharmacokinetics.
Cost Insurance
4 articles in cost insurance.
Low-Dose Briefs
Concise explainers on low-dose ketamine evidence, safety, patient questions, and treatment trends.
What PHQ-9 Score Change Counts as Real Ketamine Improvement
A 5-point PHQ-9 drop is the usual threshold for meaningful change, and 50% is response. See how thes...
BriefAfter Two Failed Antidepressants: TMS and Esketamine
A KevinMD commentary urges faster escalation to TMS and esketamine after two failed antidepressants....
BriefKetamine Remission Criteria for Depression Explained
Ketamine remission criteria for depression rely on standardized scales like MADRS and HAM-D. See the...
BriefWhen Antidepressants Fail: What Comes Next for TRD?
STAT reports on treatment-resistant depression care after oral antidepressants fail; here's how keta...
Compare low-dose options
Review routes, dosing discussions, and alternatives before speaking with a clinician.
Where to start
If you are reading about low-dose ketamine for the first time, these are the most useful jumping-off points.
Most readers come here weighing a treatment decision or preparing for an appointment. Start with the long-form guides if you want background, the conditions index if you are researching a specific diagnosis, and the FAQ if you want answers to common monitoring questions.
Browse by section
Featured guides
Recent news
Have a correction or a question?
We update guides as evidence and clinical practice evolve.
Latest Low-Dose Updates
Recent research, safety, and access updates relevant to low-dose ketamine.
ECT, TMS, and Esketamine: Mapping Options for TRD
A new Psychiatric Times review compares ECT, TMS, and esketamine for treatment-resistant depression. Here's how off-labe...
What PHQ-9 Score Change Counts as Real Ketamine Improvement
A 5-point PHQ-9 drop is the usual threshold for meaningful change, and 50% is response. See how these apply to low-dose...
Low-Dose Ketamine and Seizure Disorder Safety Guide
Does epilepsy or another seizure disorder rule out low-dose ketamine? See what the evidence and screening process show,...
Ketamine Dosing Journal Template: What to Log
A ketamine dosing journal template to log each session: dose, timing, PHQ-9/GAD-7 scores, and side effects. See what to...
After Two Failed Antidepressants: TMS and Esketamine
A KevinMD commentary urges faster escalation to TMS and esketamine after two failed antidepressants. Here's what that me...
Ketamine Dissociation and Antidepressant Response Explained
Learn what evidence says about ketamine dissociation and antidepressant response, including what clinicians monitor. Exp...
Low-Dose Comparisons
Compare routes, care models, dosing assumptions, and treatment tradeoffs.
Ketamine vs TMS (Transcranial Magnetic Stimulation): Two Approaches to Treatment-Resistant Depression
Ketamine vs TMS for treatment-resistant depression: mechanisms, success rates, protocols, side effects, FDA status, and cost compared side by side.
Read comparison →IV Racemic Ketamine vs Esketamine (Spravato): A Clinical Comparison
Evidence-based comparison of IV racemic ketamine and intranasal esketamine (Spravato) for treatment-resistant depression, examining mechanism differences, efficacy data, FDA status, cost, access, and side effects.
Read comparison →Ketamine vs Traditional Antidepressants: Mechanism, Efficacy, and Clinical Role
Ketamine vs SSRIs, SNRIs, and TCAs: how mechanisms, onset, efficacy in treatment-resistant depression, side effects, and access compare in current evidence.
Read comparison →Sublingual vs Oral (Swallowed) Ketamine: Absorption and Efficacy Differences
Compare sublingual and swallowed oral ketamine, including absorption, first-pass metabolism, onset, taste, and questions to discuss with a prescriber.
Read comparison →IV vs Oral Ketamine: Routes of Administration Compared
Compare IV and oral ketamine for depression, including absorption, research evidence, monitoring, convenience, safety planning, and questions to ask a prescriber.
Read comparison →Low-dose information is most useful when it keeps supervision and monitoring visible.
— Low Dose Ketamine
Important Disclaimer
Educational information only. Low-dose ketamine decisions require individualized clinical judgment. This site does not provide prescribing, dosing instructions, diagnosis, or emergency care.